AVDL
Avadel Pharmaceuticals
AVDL
AVDL
82 hedge funds and large institutions have $211M invested in Avadel Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
7% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $1.2M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
82
Holding in Top 10
1
Calls
$1.11M
Puts
$1.2M
Top Buyers
| 1 | +$3.9M | |
| 2 | +$3.78M | |
| 3 | +$2.91M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$1.54M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$1.25M |
Top Sellers
| 1 | -$4.16M | |
| 2 | -$2.71M | |
| 3 | -$1.95M | |
| 4 |
Millennium Management
New York
|
-$1.78M |
| 5 |
Renaissance Technologies
New York
|
-$1.27M |